NetraMark Holdings Inc C.AIAI

Conference Call Dec 5 9:00 am ET

[windymayor1]

We are pleased to invite you to a call hosted by NetraMark CEO, George Achilleos who will sit down with Dr. Luca Pani, Netramark's Chief Innovation and Regulatory Officer (brief bio below).  Dr. Pani will discuss his expert insight into how and where NetraMark will fit into the clinical trial arena, from a regulatory perspective.
 
Event Details:
• Date: Dec 5, 2024 
• Time: 9 am ET 
• Duration: 45 minutes
• Access Information: Platform - Google Meet - https://meet.google.com/hgp-zybc-spc?hs=224

Join by phone

(CA) [phone]
PIN: 962624297

[windymayor1]

Nice market reaction to today's management call. 

[toucsa]

I missed the call. Wonder if that caused the volume surge?

[windymayor1]

I would say yes. They are pursuing ISTAND.- Innovative Science and Technology Approachs for New Drugs program.. Submitting to FDA in Jan.  Its like the CSA standard for achieving Trial success and would give them regulator validation.  Imagine if every biotech/pharma trial uses AIAi?!  10,000 trials/year x $400k.  Mindboggling potential.  

[toucsa]

Thanks for the info. This just keeps on getting better!

[Trekkie]

I just picked some of this up for myself after seeing the activity. However, it sounds like a long term hold postion if they are only submitting to FDA now. Let's hope it does well! 

[toucsa]

I believe there is a lot more than ISTAND going on behind the curtain. Anyway welcome aboard and strap up for the ride.